MedPath

Duloxetine in ADHD

Phase 2
Conditions
ADHD.
Disturbance of activity and attention
Registration Number
IRCT138810193029N1
Lead Sponsor
Tehran University of Medical Sciences and Health services
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Diagnosis of ADHD according to DSM-IV-TR Criteria, age range of 11 to 18 years
Exclusion criteria: Presence of mental retardation, cardiac problems, known contraindications to study drugs, Comorbidity of severe major depression, conduct disorder, bipolar or psychotic disorders, epilepsy taking anticonvulsants at the time of enrollment and during the trial, pregnancy or lactation, refusal to participate

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ADHD severity of symptoms. Timepoint: Baseline, Every 2 weeks, End point. Method of measurement: Conner's and ADHD rating Scale.
Secondary Outcome Measures
NameTimeMethod
Drug side effects. Timepoint: every 2 weeks and end point. Method of measurement: Questionnaire.
© Copyright 2025. All Rights Reserved by MedPath